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Abstract
Background: Light-chain (AL) cardiac amyloidosis (CA) is characterized by fibril deposits, which are composed of 
monoclonal immunoglobulin light chains. The right ventricle is mostly involved in AL-CA and impairment of its function 
is a predictor of worse prognosis.
Objectives: To characterize the volumetric and functional properties of the right atrium (RA) in AL-CA by three-dimensional 
speckle-tracking echocardiography (3DSTE).
Methods: A total of 16 patients (mean age: 64.5 ± 10.1 years, 11 males) with AL-CA were examined. Their results were compared 
to that of 15 age- and gender-matched healthy controls (mean age: 58.9 ± 6.9 years, 8 males). All cases have undergone 
complete two-dimensional Doppler and 3DSTE. A two-tailed p value of less than 0.05 was considered statistically significant.
Results: Significant differences could be demonstrated in RA volumes respecting cardiac cycle. Total (19.2 ± 9.3% vs. 
27.9 ± 10.7%, p = 0.02) and active atrial emptying fractions (12.1 ± 8.1 vs. 18.6 ± 9.8%, p = 0.05) were significantly 
decreased in AL-CA patients. Peak global (16.7 ± 10.3% vs. 31.2 ± 19.4%, p = 0.01) and mean segmental (24.3 ± 11.1% 
vs. 38.6 ± 17.6%, p =0.01) RA area strains, together with some circumferential, longitudinal and segmental area strain 
parameters, proved to be reduced in patients with AL-CA. Global longitudinal (4.0 ± 5.2% vs. 8.2 ± 5.5%, p = 0.02) 
and area (7.8 ± 8.1% vs. 15.9 ± 10.3%, p = 0.03) strains at atrial contraction and some circumferential and area strain 
parameters at atrial contraction were reduced in AL-CA patients.
Conclusion: Significantly increased RA volumes and deteriorated RA functions could be demonstrated in AL-CA. (Arq Bras 
Cardiol. 2018; 111(3):384-391)
Keywords: Amyloidosis; Echocardiography, Three Dimensional / methods; Humans; Ventricular Dysfunction, Right; 
Speckle-Tracking.
Introduction
Systemic amyloidosis is a rare disease caused by the 
extracellular deposition of protein (amyloid) fibrils, which 
are composed of low molecular weight subunits (5 to 25 kD) 
of various serum proteins.1 The amyloid fibrils progressively 
damage the structure and function of the affected tissue, with 
variable clinical symptoms.2,3 For diagnosis of amyloidosis, 
biopsy from the affected tissue or from (abdominal) 
subcutaneous adipose tissue is necessary in most of cases.4 
The classification of amyloidosis depends on the type of 
the precursor protein, including acquired monoclonal 
immunoglobulin light-chain amyloidosis (AL), wild-type or 
hereditary transthyretin amyloidosis (TTR), acquired serum 
amyloid type (AA) and other rare types. The mortality is 
especially high in light-chain (AL) amyloidosis.5,6
There are some warning signs that can draw attention to 
amyloidosis, such as nephrotic syndrome, tissue infiltration such 
as macroglossia, respiratory disease, carpal tunnel syndrome, 
bleeding, cachexia, haematological disease such as multiple 
myeloma, and genetic predisposition. As for the clinical signs, 
syncope is a poor prognostic factor and occurs quite frequently 
in patients with cardiac involvement.7 Cardiac involvement in 
amyloidosis varies according to the type of the disease.1 The real 
incidence of cardiac amyloidosis (CA) is not known precisely 
and is often diagnosed only during autopsy.8 Heart failure usually 
occurs in CA due to the combination of decreased myocardial 
compliance and compressed myocardial cells. These changes 
develop due to the infiltration by amyloid deposits and could 
lead to restrictive cardiomyopathy.1 Arrhythmias, pleural and 
pericardial effusion can also be detected in some cases.4,9,10 
Although the right ventricle (RV) is mostly involved in CA, limited 
data is available about the involvement of the right atrium (RA).11,12 
Therefore, this study aimed to characterize the volumetric and 
functional properties of the RA in AL-CA by three-dimensional 
(3D) speckle-tracking echocardiography (3DSTE).
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Methods
Patient population
A total of 16 patients (mean age: 64.5 ± 10.1 years, 11 males) 
with biopsy-proven AL-CA were examined. Their results 
were compared to that of 15 age- and gender-matched 
healthy controls (mean age: 58.9 ± 6.9 years, 8 males). 
Baseline demographic characteristics of patients and controls are 
presented in Table 1. CA was defined in accordance with the 
current consensus criteria and practices.6,13 None of the patients 
with AL-CA was on anticoagulant treatment, but 2 of them 
received acetylsalicylic acid. Five patients received β-blockers, 
7 patients were on angiotensine-converting enzyme inhibitors, 
while 11 patients took diuretics. The source of the biopsy was the 
bone marrow in 3 patients, the subcutis in 3 patients, the kidney 
in 5 patients, the heart in 3 patients, the gastrointestinal tract in 
4 patients and the salivary gland in 1 patient. In 3 cases, samples 
were collected from more than 1 organ. In 11 out of 16 AL-CA 
patients, the diagnosis of multiple myeloma was confirmed. 
In 1 case, no treatment information was available. In all other 
cases, different types of chemotherapy or immunomodulatory 
treatment were administered. None of the healthy subjects in 
the control group had cardiovascular risk factors or any known 
diseases or received any medications. For cardiac evaluation, 
complete two-dimensional (2D) Doppler, tissue Doppler 
echocardiography, 3DSTE and N-terminal pro-B natriuretic 
peptide (NT-proBNP) level assessment were performed in 
all patients and controls. The present study was designed as 
a part of the Motion Analysis of the heart and Great vessels 
bY three-dimensionAl speckle-tRacking echocardiography in 
Pathological cases (MAGYAR-Path) Study. It has been organized 
to examine alterations in 3DSTE-derived parameters in different 
disorders compared to matched healthy controls among 
others (magyar means “Hungarian” in Hungarian language). 
The study protocol conformed to the ethical guidelines of the 
1975 Declaration of Helsinki (and updated versions) and was 
approved in advance by the local institutional ethical committee. 
Informed consent was obtained from each subject.
Two-dimensional Doppler echocardiography
2D grayscale harmonic images were performed in the 
lateral decubitus position with using a commercially available 
ultrasound system (ArtidaTM, Toshiba Medical Systems, Tokyo, 
Japan) equipped with a broadband 1-5 MHz PST-30SBP 
phased-array transducer. During 2D Doppler echocardiography, 
chamber dimensions, volumes and ejection fraction were 
measured in accordance with the recommendations.14,15 
Degree of mitral and tricuspid regurgitations was visually 
quantified by colour Doppler echocardiography.
Three-dimensional speckle-tracking echocardiography
3D echocardiographic datasets were acquired with the 
same Toshiba Artida ultrasound system with a 1-4 MHz 
PST-25SX matrix phased-array transducer.16 After gain setting 
optimalisation, wide-angled pictures were recorded, in 
which 6 wedge-shaped subvolumes were acquired over 
6 consecutive cardiac cycles during a single breath-hold. 
We used raw data format for further analysis. 3D Wall Motion 
Tracking software version 2.7 (Toshiba Medical Systems, Tokyo, 
Japan) was used for RA quantifications. Each 3D dataset was 
displayed in a 5-plane view: an apical 4-chamber (AP4CH) 
view, an apical 2-chamber (AP2CH) view and 3 short-axis 
views at different RA levels from the base to the apex. 
The examiner then set markers in the AP4CH and AP2CH 
views; in each plane, one marker was placed on the apex 
(superior region) and two other markers were placed at the 
edges of the tricuspid valve ring. As the next step, the software 
automatically detected the endocardium, and 3D wall motion-
tracking analysis was performed through the entire cardiac 
cycle. During evaluations, RA appendage and the caval veins 
were excluded from the RA cavity (Figure 1).
From the acquired 3D echocardiographic datasets, time-global 
RA volume curves were created, allowing the measurement of 
maximum (Vmax) and minimum (Vmin) RA volumes and RA volume 
before atrial contraction (VpreA). Vmax was measured just before 
tricuspid valve opening at end-systole, while Vmin and VpreA were 
measured just before tricuspid valve closure at end-diastole and 
at the time of P wave on ECG in early diastole, respectively. 
The systolic reservoir and diastolic passive (conduit) and active 
emptying (booster pump) phases of RA function were measured 
from the RA volumetric datasets:17
Right atrial stroke volumes
– Total Atrial Stroke Volume (TASV): Vmax−Vmin 
(reservoir function)
– Passive Atrial Stroke Volume (PASV): Vmax–VpreA 
(conduit function)
– Active Atrial Stroke Volume (AASV): VpreA−Vmin (booster 
pump/active contraction function)
Right atrial emptying fractions
– Total Atrial Emptying Fraction: TASV/Vmax×100 
(reservoir function)
– Passive Atrial Emptying Fraction: PASV/Vmax×100 
(conduit function) 
– Active Atrial Emptying Fraction: AASV/VpreA×100 
(booster pump/active contraction function) 
Time-strain curves could also be created at the same time 
from the same 3D echocardiographic datasets. Unidirectional 
radial, longitudinal, circumferential and complex area and 
3D strains could be also measured. Global strains were 
calculated by the software, which considered the whole RA, 
while mean segmental strains were obtained as the average 
of strains of 16 segments. A typical strain curve usually 
represents two peaks: the first peak indicates the reservoir 
phase, while the second peak shows characteristics of the 
booster pump phase of the RA function.17
Statistical analysis
All continuous variables were presented as mean ± 
standard deviation. Categorical data were presented as 
frequencies and percentages (%). Comparisons among groups 
were performed by unpaired Student t test and χ2 test, when 
appropriate. Shapiro-Wilks test was used to test normal 
distribution in every dataset. Pearson correlation coefficient 
was calculated when needed. A 2-tailed p value < 0.05 was 
considered to indicate statistical significance. Reproducibility 
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Figure 1 – Images from three-dimensional (3D) full-volume dataset showing the right atrium (RA) are presented: apical four-chamber (A) and two-chamber views 
(B) and short-axis views at basal (C3), mid- (C5) and superior (C7) RA levels together with a virtual 3D model of the RA (red D) and with RA volumetric data (red E). 
Time – segmental (longitudinal) strain curves of all 16 RA segments (coloured lines) and a time - global RA volume change curve respecting cardiac cycle (white dashed 
line) are also presented (red F). Yellow arrow represents peak RA strain, while yellow dashed arrow represents RA strain at atrial contraction. Vmax, Vmin and VpreA represent 
maximum and minimum RA volumes and RA volume at atrial contraction, respectively. LV: left ventricle; LA: left atrium; RV: right ventricle; RA: right atrium.
Table 1 – Baseline demographic and two-dimensional echocardiographic data in patients with cardiac amyloidosis and matched controls
AL-CA patients (n = 16) Controls (n = 15) p-value
Risk factors
Age (years) 64.5 ± 10.1 58.9 ± 6.9 0.08*
Male gender (%) 11 (69) 8 (53) 0.47**
Hypertension (%) 11 (69) 0 (0) < 0.0001**
Diabetes mellitus (%) 1 (6) 0 (0) 0.46**
Hypercholesterolaemia (%) 6 (38) 0 (0) 0.02**
Two-dimensional echocardiography
LA diameter (mm) 45.1 ± 6.7 36.6 ± 4.00 < 0.0001*
LV end-diastolic diameter (mm) 47.1 ± 5.7 47.3 ± 3.2 0.93*
LV end-diastolic volume (ml) 112.9 ± 31.9 104.9 ± 16.7 0.42*
LV end-systolic diameter (mm) 30.0 ± 5.3 30.4 ± 2.8 0.80*
LV end-systolic volume (ml) 41.7 ± 15.4 35.7 ± 6.9 0.11*
Interventricular septum (mm) 14.2 ± 1.9 10.4 ± 1.7 < 0.0001*
LV posterior wall (mm) 13.6 ± 1.7 10.4 ± 1.9 0.0003*
LV ejection fraction (%) 61.5 ± 11.9 65.7 ± 4.8 0.21*
E/A 1.71 ± 1.08 1.00 ± 0.45 0.14*
CA: cardiac amyloidosis; LA: left atrial; LV: left ventricular. Data expressed as mean ± standard deviation or or absolute numbers (percentage). * Unpaired Student 
t test, **χ2 test.
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of 3DSTE-derived RA assessments has already been confirmed 
in a recent study.17 All statistical analyses were carried out 
using MedCalc software (MedCalc, Inc., Mariakerke, Belgium).
Results
Two-dimensional Doppler echocardiographic and NT-
proBNP data
Significantly increased left atrial diameter, interventricular 
septum (IVS) and left ventricular (LV) posterior wall could be 
demonstrated in AL-CA patients as compared to matched controls 
(Table 1). Significant differences could be detected between 
AL-CA patients and matched controls in tricuspid annular plane 
systolic excursion (16.7 ± 3.1 mm vs. 20.0 ± 1.8 mm, p = 0.05) 
and RV fractional area change (32.3 ± 5.3% vs. 39.2 ± 3.5%, 
p = 0.04). Significant (≥ grade 3) mitral regurgitation could not be 
detected in any of the patients or control subjects. Only 1 patient 
with AL-CA had grade 4 tricuspid regurgitation. NT-proBNP level 
proved to be 9983 ± 11101 U/l in AL-CA patients.
Three-dimensional speckle tracking echocardiographic data
Significant differences could be demonstrated in all RA 
volumes respecting the cardiac cycle. Total and active atrial 
emptying fractions were significantly decreased in AL-CA 
patients, while RA stroke volumes did not differ between the 
groups examined (Table 2). Peak global and mean segmental 
area strains proved to be reduced in AL-CA patients as 
compared to that of matched controls. Midatrial segmental 
circumferential, longitudinal and area strains, together with 
some basal strains, proved to be reduced in patients with 
AL-CA (Tables 3-4). Global longitudinal and area strains at 
atrial contraction were impaired in AL-CA patients, together 
with midatrial segmental circumferential and area strains 
(Tables 5-6). These results could suggest impaired longitudinal 
and circumferential RA function in the reservoir and active 
contraction phases of the RA function. Alterations in 
segmental RA strains could suggest non-uniformity of RA 
dysfunction in these cases.
Discussion
Among several types of amyloidosis, in AL amyloidosis 
is characterized by fibril deposits, which are composed 
of monoclonal immunoglobulin light chains and is mainly 
associated with B-cell type diseases, like clonal plasma cell 
or other B-cell dyscrasias.18 The course of the disease can be 
progressive in case of cardiac involvement.19 The main cause 
of death in patients with AL amyloidosis is cardiac involvement 
leading to heart failure or arrhythmias, and is considered to be 
an important prognostic factor. Without cardiac presentation, 
the survival is 4 years,20 in some cases, it is only 8 months.21
In case of cardiac involvement, typically concentric 
ventricular thickening with RV involvement, biventricular 
function with normal or near normal ejection fraction 
and valvular thickening can be seen.22,23 The speckled or 
granular myocardial appearance is characteristic of amyloid 
deposit, but the absence of this phenomenon is not rare.2 
Disproportionate septal deposition can mimic hypertrophic 
cardiomyopathy with dynamic LV outflow tract obstruction. 
Atrial thrombus is common, especially in AL-CA, and sometimes 
is associated to atrial fibrillation. Diastolic dysfunction is the 
earliest echocardiographic sign and can often be detected 
before any clinical symptom.24,25 The end-diastolic thickness 
of the IVS is > 12 mm in the absence of any other cause of LV 
hypertrophy in heart involvement.13 In CA, the thickness of the 
LV wall is not in correlation with the course and outcome of 
Table 2 – Comparison of 3DSTE-derived volumetric and volume-based functional right atrial parameters in patients with cardiac amyloidosis 
and in matched controls
AL-CA patients (n = 16) Controls (n = 15) p-value
Calculated Volumes
Vmax (ml) 85.0 ± 40.2 43.0 ± 13.2 < 0.0001*
Vmin (ml) 69.8 ± 37.3 30.8 ± 9.2 < 0.0001*
VpreA (ml) 79.2 ± 41.0 38.2 ± 12.8 < 0.0001*
Stroke Volumes
TASV (ml) 15.2 ± 9.2 12.2 ± 7.3 0.40*
PASV (ml) 5.8 ± 5.1 4.8 ± 3.1 0.98*
AASV (ml) 9.4 ± 8.6 7.4 ± 5.9 0.47*
Emptying fractions
TAEF (%) 19.2 ± 9.3 27.9 ± 10.7 0.02*
PAEF (%) 7.9 ± 8.0 11.5 ± 6.8 0.07*
AAEF (%) 12.1 ± 8.1 18.6 ± 9.8 0.05*
3DSTE: three-dimensional speckle-tracking echocardiography; CA: cardiac amyloidosis; AAEF: active atrial emptying fraction; AASV: active atrial stroke volume; 
PAEF: passive atrial emptying fraction; PASV: passive atrial stroke volume; TAEF: total atrial emptying fraction; TASV: total atrial stroke volume; Vmax: maximum 
right atrial volume; Vmin: minimum right atrial volume; VpreA: right atrial volume before atrial contraction. Data expressed as mean ± standard deviation.  
* Unpaired Student t test.
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Table 3 – Comparison of 3DSTE-derived peak global and segmental peak right atrial strain parameters in patients with cardiac amyloidosis 
and in matched controls
AL-CA patients (n = 16) Controls (n = 15) p-value
Peak global strain
RS (%) -13.8 ± 8.8 -15.1 ± 7.2 0.52*
CS (%) 7.1 ± 5.7 10.7 ± 9.6 0.21*
LS (%) 14.4 ± 9.8 21.9 ± 9.3 0.18*
3DS (%) -6.9 ± 6.2 -8.1 ± 4.8 0.55*
AS (%) 16.7 ± 10.3 31.2 ± 19.4 0.01*
Peak mean segmental strain
RS (%) -17.1 ± 8.8 -18.9 ± 6.6 0.54*
CS (%) 12.2 ± 6.3 16.0 ± 9.2 0.19*
LS (%) 16.1 ± 9.3 24.2 ± 9.6 0.10*
3DS (%) -11.5 ± 6.1 -12.6 ± 4.7 0.60*
AS (%) 24.3 ± 11.1 38.6 ± 17.6 0.01*
3DSTE: three-dimensional speckle-tracking echocardiography; CA: cardiac amyloidosis; 3DS: three-dimensional strain; AS: area strain; CS: circumferential strain; 
LS: longitudinal strain; RS: radial strain. Data expressed as mean ± standard deviation. * Unpaired Student t test.
Table 4 – Comparison of 3DSTE-derived peak segmental right atrial strain parameters in patients with cardiac amyloidosis and in matched controls
AL-CA patients (n = 16) Controls (n = 15) p-value
RS basal (%) -16.3 ± 10.2 -16.8 ± 5.7 0.87*
RS mid (%) -14.9 ± 7.7 -18.5 ± 7.9 0.21*
RS superior (%) -21.7 ± 16.5 -22.5 ± 11.9 0.87*
CS basal (%) 10.2 ± 4.9 15.1 ± 7.2 0.03*
CS mid (%) 7.9 ± 5.7 13.1 ± 6.9 0.02*
CS superior (%) 21.8 ± 16.7 20.8 ± 21.9 0.53*
LS basal (%) 17.6 ± 8.6 24.4 ± 13.4 0.19*
LS mid (%) 18.0 ± 13.3 30.7 ± 13.1 0.01*
LS superior (%) 10.9 ± 10.5 16.8 ± 9.9 0.07*
3DS basal (%) -11.6 ± 7.2 -11.2 ± 5.3 0.86*
3DS mid (%) -9.6 ± 5.6 -12.0 ± 5.9 0.24*
3DS superior (%) -14.3 ± 10.8 -15.4 ± 9.3 0.77*
AS basal (%) 19.9 ± 9.1 30.1 ± 12.7 0.02*
AS mid (%) 21.9 ± 15.9 41.0 ± 15.4 0.002*
AS superior (%) 34.4 ± 30.9 47.9 ± 48.3 0.66*
3DSTE: three-dimensional speckle-tracking echocardiography; CA: cardiac amyloidosis; 3DS: three-dimensional strain; AS: area strain; CS: circumferential strain; 
LS: longitudinal strain; RS: radial strain. Data expressed as mean ± standard deviation. * Unpaired Student t test.
the disease.6 Doppler myocardial imaging measures of the RV 
can identify early impairment of cardiac function or stratify risk 
of death in patients with AL-CA.26 Impaired RV function was 
found to be a predictor of worse prognosis of early mortality 
in AL-CA.27 However, detailed analysis of AL-CA-associated RA 
volumetric and functional alterations was not documented.
With 2D echocardiography, the assessment of RA 
is limited due to viewing dependency and geometric 
difficulties. Regularly, RA diameter and area are measured 
in AP4CH view.14,15 3D echocardiography is a new clinical 
modality that allows the accurate measurement of atrial 
phasic volume changes.12,16,17 Moreover, several functional 
properties, including stroke volumes and emptying fractions 
and strains at different phases of the cardiac cycle, could 
be measured at the same time from the same 3D dataset, 
allowing detailed analysis of the RA during 3DSTE.16,17 
In the present study, over increased RA volumes in all phases, 
alterations in emptying fractions and strains characterizing 
systolic reservoir, and late-diastolic active booster pump RA 
functions could be demonstrated. These findings could be 
explained by infiltration of the atrial wall with amyloid fibrils, 
impaired left and/or right heart failure, effects of cardiovascular 
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Table 5 – Comparison of 3DSTE-derived global and segmental peak right atrial strain parameters at atrial contraction in patients with cardiac 
amyloidosis and in matched controls
AL-CA patients (n = 16) Controls (n = 15) p-value
Global strain at atrial contraction
RS (%) -6.4 ± 6.7 -6.2 ± 6.1 0.93*
CS (%) 10.6 ±11.9 7.8 ± 8.5 0.47*
LS (%) 4.0 ± 5.2 8.2 ± 5.5 0.02*
3DS (%) -2.8 ± 4.9 -3.6 ± 4.4 0.62*
AS (%) 7.8 ± 8.1 15.9 ± 10.3 0.03*
Mean segmental strain at atrial contraction
RS (%) -8.5 ± 6.0 -8.5 ± 4.8 0.99*
CS (%) 5.3 ± 6.2 8.6 ± 7.3 0.10*
LS (%) 6.5 ± 4.0 9.0 ± 5.7 0.20*
3DS (%) -5.3 ± 4.6 -6.2 ± 4.5 0.57*
AS (%) 11.2 ± 6.8 17.2 ± 12.3 0.11*
3DSTE: three-dimensional speckle-tracking echocardiography; CA: cardiac amyloidosis; 3DS: three-dimensional strain; AS: area strain; CS: circumferential strain; 
LS: longitudinal strain; RS: radial strain. Data expressed as mean ± standard deviation. *Unpaired Student t test.
risk factors, haemodynamic reasons, local fibrosis or oedema. 
In a recent study, severe LA dysfunction could be demonstrated 
in AL-CA, therefore the role of LA-RA interactions could also 
not be excluded.28 Segmental RA strain analyses showed RA 
regional differences, suggesting their different contributions 
to RA (dys)function, as mentioned before (non-uniformity 
of RA dysfunction). Further studies are needed to confirm 
our findings in a larger population, comparing results to 
other diseases with LV hypertrophy as well. It should also 
be examined whether the demonstrated pattern of RA 
Table 6 – Comparison of 3DSTE-derived segmental right atrial strain parameters at atrial contraction in patients with cardiac amyloidosis and 
in matched controls
AL-CA patients (n = 16) Controls (n = 15) p-value
RS basal (%) -9.6 ± 9.4 -8.5 ± 5.7 0.72*
RS mid (%) -7.2 ± 5.5 -7.5 ± 4.5 0.89*
RS superior (%) -9.0 ± 8.2 -10.2 ± 7.5 0.67*
CS basal (%) 4.6 ± 4.4 10.1 ± 10.5 0.07*
CS mid (%) 3.6 ± 4.4 8.4 ± 6.2 0.02*
CS superior (%) 10.6 ± 11.9 7.4 ± 9.8 0.42*
LS basal (%) 7.7 ± 4.0 8.9 ± 6.3 0.53*
LS mid (%) 6.8 ± 6.9 10.6 ± 7.3 0.12*
LS superior (%) 4.1 ± 5.7 7.0 ± 7.7 0.20*
3DS basal(%) -5.4 ± 7.0 -6.0 ± 5.2 0.81*
3DS mid(%) -4.2 ± 4.1 -6.0 ± 4.5 0.27*
3DS superior (%) -6.8 ± 6.9 -7.1 ± 6.5 0.90*
AS basal (%) 9.9 ± 5.4 16.0 ± 10.6 0.06*
AS mid (%) 9.4 ± 9.1 18.2 ± 12.4 0.03*
AS superior (%) 15.9 ± 19.8 17.2 ± 22.3 0.87*
3DSTE: three-dimensional speckle-tracking echocardiography; CA: cardiac amyloidosis; 3DS: three-dimensional strain; AS: area strain; CS: circumferential strain; 
LS: longitudinal strain; RS: radial strain. Data expressed as mean ± standard deviation. * Unpaired Student t test.
dysfunction is specific or not for AL-CA, and whether it has 
or not a diagnostic or prognostic value.
Limitations
The limited number of patients with AL-CA is one of the 
most important limitations of the study. However, biopsy-proven 
amyloidosis with cardiac involvement is a rare disease. 
Although the atrial septum is part of both atria, it was considered 
to be part of the RA in this study.
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